Regenxbio (RGNX) Return on Capital Employed Growth (1y) (2016 - 2025)
Regenxbio (RGNX) Return on Capital Employed Growth (1y) (2016 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
ROCE Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
68,255.00 |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
2,665.00 |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
31,429.00 |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
2,503.00 |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
16,829.00 |
| 10 |
Regenxbio |
325.94 Mn |
95.87 Mn |
- |
1,648.00 |
| Date | Value |
|---|
| Dec 31, 2025 |
1,648.00 |
| Sep 30, 2025 |
1,954.00 |
| Jun 30, 2025 |
1,013.00 |
| Mar 31, 2025 |
1,176.00 |
| Dec 31, 2024 |
-332.00 |
| Sep 30, 2024 |
-633.00 |
| Jun 30, 2024 |
-477.00 |
| Mar 31, 2024 |
-1,613.00 |
| Dec 31, 2023 |
-2,051.00 |
| Sep 30, 2023 |
-6,301.00 |
| Jun 30, 2023 |
-5,885.00 |
| Mar 31, 2023 |
-5,192.00 |
| Dec 31, 2022 |
-5,546.00 |
| Sep 30, 2022 |
4,277.00 |
| Jun 30, 2022 |
3,171.00 |
| Mar 31, 2022 |
3,164.00 |
| Dec 31, 2021 |
4,130.00 |
| Sep 30, 2021 |
-460.00 |
| Jun 30, 2021 |
1,964.00 |
| Mar 31, 2021 |
1,588.00 |
